AI MARKET SCANNING

$ENGN

enGene Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP2.59%
MAX GAP RECORD9.73%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $ENGN

EXECUTIONS4 LOGS
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
2026-09-10QUANT ALGOBUY x5$•••.•• → $•••.••2498m🔒 ENCRYPTED-19.93%
••••-••-••🔒 LOCKED••• x•$•••.•• → $•••.••••h ••m🔒 LOCKED+••.••%
••••-••-••🔒 LOCKED••• x•$•••.•• → $•••.••••h ••m🔒 LOCKED+••.••%
••••-••-••🔒 LOCKED••• x•$•••.•• → $•••.••••h ••m🔒 LOCKED+••.••%
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.9%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24,… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL